Rev Esp Quimioter 2024, 37(4): 334-340
Dalbavancin as consolidation therapy for infective endocarditis in patients with comorbidity. A real world experience
DAVID BRANDARIZ-NÚÑEZ, ANDREA LUANCES-RODRÍGUEZ, PABLO FEIJOO-VILANOVA, JOSÉ MARÍA GUTIÉRREZ-URBÓN, LUIS RAMUDO-CELA, MARÍA ISABEL MARTÍN-HERRANZ, LUIS MARGUSINO-FRAMIÑÁN
Published: 17 June 2024
http://www.doi.org/10.37201/req/012.2024
Introduction. Infective endocarditis (IE) is a potentially life-threatening infection, the incidence of which has in creased in recent decades, particularly among elderly patients with comorbidity. The primary objective of this study was to evaluate the effectiveness of dalbavancin in the consolidation therapy of IE in patients with comorbidity six months after the end of treatment (EOT).
Material and methods. An observational and retrospective study was conducted on patients with a Charlson Comorbidity Index (CCI) ≥ 3 who were diagnosed with IE and received consolidation therapy with dalbavancin.
Results. Forty-eight patients were included, 58.3% were male, mean age of 76.2 years (IQR: 66-88), and a mean age adjusted CCI of 6.5 (IQR: 5-7.5). Definite IE was diagnosed in 77% of cases. The most frequently isolated microorganisms were Staphylococcus aureus (45.8%) followed by Enterococcus spp. (31.3%). Complications of IE were observed in 67.7% of cases, and cardiac surgery was performed in 27% of patients. The primary reason for using dalbavancin was outpatient parenteral antibiotic therapy in 85.4% of cases. The effectiveness at EOT was 93.8%. At six months, six IE-related deaths, four unrelated deaths, and two IE relapses were observed. The effectiveness was 77%. Adverse effects related to DBV were reported in 4.2% of cases, of which 2% were considered serious.
Conclusion. Dalbavancin has proven to be an effective alternative as consolidation antibiotherapy for IE in elderly patients with comorbidity. Moreover, a very favorable safety profile with few associated adverse effects has been observed in this population.
Rev Esp Quimioter 2024; 37(4): 334-340 [Full-text PDF] [Supplementary material PDF]
